OnTrack Diabetes
Webinars & Podcasts

Episode 32: All About Afrezza

A Type 2 and the CEO of Mannkind Corp. Discuss How Inhalable Insulin Can Be Used to Manage Diabetes

Featured Guests
Michael Castagna, PharmD, Mannkind Corporation CEO, Joel Friedman, MD, a patient living with type 2 diabetes

Afrezza Rapid Acting Inhalable InsulinAfrezza is the only rapid-acting insulin that is inhaled instead of injected. Learn more about the benefits and challenges of this unique form of insulin from a type 2 who uses it and the CEO of Mankind Corp. who helped develop it.

YES! I want to listen to the FREE podcast Episode 32: All About Afrezza – and receive tips and updates from OnTrack Diabetes.
No, thanks. Please continue without signing up for the tips.